These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9636535)

  • 1. Cytomegalovirus infection and prophylaxis in renal transplantation: financial considerations.
    Wright FH; Banowsky LH
    Transplant Proc; 1998 Jun; 30(4):1318-9. PubMed ID: 9636535
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary?
    Smith SR; Butterly DW; Conlon PJ; Harland RC; Emovon OE
    Transplant Proc; 1998 Aug; 30(5):2097-9. PubMed ID: 9723404
    [No Abstract]   [Full Text] [Related]  

  • 3. Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation.
    Jung C; Engelmann E; Borner K; Offermann G
    Transplant Proc; 2001; 33(7-8):3621-3. PubMed ID: 11750538
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practice.
    Mauskopf JA; Richter A; Annemans L; Maclaine G
    Pharmacoeconomics; 2000 Sep; 18(3):239-51. PubMed ID: 11147391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal allograft outcome from cytomegalovirus seronegative donor into cytomegalovirus seronegative recipient: poor prognosis after seroconversion.
    Besse T; Malaise J; De Meyer M; Mourad M; Squifflet JP
    Transplant Proc; 2000 Mar; 32(2):408-10. PubMed ID: 10715458
    [No Abstract]   [Full Text] [Related]  

  • 6. The economic value of valacyclovir prophylaxis in transplantation.
    Squifflet JP; Legendre C
    J Infect Dis; 2002 Oct; 186 Suppl 1():S116-22. PubMed ID: 12353196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior efficacy of oral ganciclovir over oral acyclovir for cytomegalovirus prophylaxis in kidney-pancreas and pancreas alone recipients.
    Somerville T; Hurst G; Alloway R; Gaber A; Shokouh-Amiri MH; Stratta R
    Transplant Proc; 1998 Jun; 30(4):1546-8. PubMed ID: 9636628
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacoeconomic impact of different regimens to prevent cytomegalovirus infection in renal transplant recipients.
    Kielberger L; Bouda M; Jindra P; Reischig T
    Kidney Blood Press Res; 2012; 35(6):407-16. PubMed ID: 22584353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.
    Pouteil-Noble C; Megas F; Chapuis F; Bosshard S; Colin C; Hadj-Aissa A; Pozet N; Martin X; Lefrançois N; Garnier JL; Aymard M; Touraine JL
    Transplant Proc; 1996 Oct; 28(5):2811. PubMed ID: 8908072
    [No Abstract]   [Full Text] [Related]  

  • 10. Ganciclovir prophylaxis of cytomegalovirus disease.
    Conti DJ; Shen G; Singh T; Isenberg A; Freed BM
    Transplant Proc; 1997; 29(1-2):804-6. PubMed ID: 9123534
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy and cost-effectiveness of valacyclovir in cytomegalovirus prevention in solid organ transplantation.
    Reischig T; Kacer M
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):771-9. PubMed ID: 25252996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMV infection as a contributory factor for renal allograft injury and loss.
    Gerstenkorn C; Robertson H; Bell A; Shenton B; Talbot D
    Transplant Proc; 2001 Jun; 33(4):2461-2. PubMed ID: 11406211
    [No Abstract]   [Full Text] [Related]  

  • 13. A decision-analytic economic evaluation of valaciclovir prophylaxis for the prevention of cytomegalovirus infection and disease in renal transplantation.
    Tilden DP; Chapman J; Davey PJ; Solly ML; Crowley S
    Clin Transplant; 2004 Jun; 18(3):312-20. PubMed ID: 15142054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoeconomic analysis of preemptive gancyclovir therapy in the prevention of cytomegalovirus infections in high-risk renal graft recipients.
    Chak WL; Choi KS; Wong KM; Chan YH; Chau KF; Li CS
    Transplant Proc; 2003 Feb; 35(1):280-1. PubMed ID: 12591399
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantation.
    Jassal SV; Roscoe JM; Zaltzman JS; Mazzulli T; Krajden M; Gadawski M; Cattran DC; Cardella CJ; Albert SE; Cole EH
    J Am Soc Nephrol; 1998 Sep; 9(9):1697-708. PubMed ID: 9727379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits.
    Bertoni E; Rosati A; Zanazzi M; Moscarelli L; Di Maria L; Piperno R; Orsi A; Parri F; Dedola G; Salvadori M
    Transplant Proc; 1998 Aug; 30(5):2094. PubMed ID: 9723402
    [No Abstract]   [Full Text] [Related]  

  • 17. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients.
    Conti DJ; Isenberg A; Shen GK; Hahn A; Singh TP
    Transplant Proc; 1998 Jun; 30(4):1314-5. PubMed ID: 9636533
    [No Abstract]   [Full Text] [Related]  

  • 19. Valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus: an economic perspective.
    Kacer M; Kielberger L; Bouda M; Reischig T
    Transpl Infect Dis; 2015 Jun; 17(3):334-41. PubMed ID: 25824586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.
    Reischig T; Opatrny K; Bouda M; Treska V; Jindra P; Svecova M
    Transpl Int; 2002 Dec; 15(12):615-22. PubMed ID: 12478408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.